Novonesis
404.1
DKK
-0.3 %
NSIS B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
21 following
-0.3%
-1.2%
-10.56%
-8.64%
-7.19%
+8.89%
+11.94%
-21.26%
+27.16%
+992.16%
investors.novozymes.com/investors/default.aspx
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Revenue
17.9B
EBIT %
22.21 %
P/E
37.01
Dividend yield-%
1.53 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
NSIS B
Daily low / high price
401.9 / 405.1
DKK
Market cap
189.24B DKK
Turnover
29.01M DKK
Volume
72K
Financial calendar
Annual report
26.02.2025
General meeting
03.04.2025
Interim report
13.08.2025
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Novo Holdings A/S | 25.5 % | 72.4 % |
ShowingAll content types
Novonesis will host an educational conference call on Energy on December 18
Major shareholder announcement
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools